Quantum BioPharma Statistics
Total Valuation
QNTM has a market cap or net worth of $7.02 million. The enterprise value is $3.50 million.
Important Dates
The next estimated earnings date is Saturday, November 23, 2024, after market close.
| Earnings Date | Nov 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
QNTM has 1.30 million shares outstanding. The number of shares has increased by 3.11% in one year.
| Shares Outstanding | 1.30M |
| Shares Change (YoY) | +3.11% |
| Shares Change (QoQ) | +5.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.99 |
| Quick Ratio | 1.96 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -519.08 |
Financial Efficiency
Return on equity (ROE) is -63.89% and return on invested capital (ROIC) is -49.41%.
| Return on Equity (ROE) | -63.89% |
| Return on Assets (ROA) | -36.12% |
| Return on Capital (ROIC) | -49.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$439,391 |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.26% in the last 52 weeks. The beta is 0.85, so QNTM's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -95.26% |
| 50-Day Moving Average | 5.55 |
| 200-Day Moving Average | 30.73 |
| Relative Strength Index (RSI) | 39.63 |
| Average Volume (20 Days) | 162,293 |
Short Selling Information
The latest short interest is 176,966, so 13.61% of the outstanding shares have been sold short.
| Short Interest | 176,966 |
| Short Previous Month | 42,430 |
| Short % of Shares Out | 13.61% |
| Short % of Float | 11.47% |
| Short Ratio (days to cover) | 0.11 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.59M |
| Pretax Income | n/a |
| Net Income | -7.47M |
| EBITDA | -10.06M |
| EBIT | -10.59M |
| Earnings Per Share (EPS) | -$12.05 |
Full Income StatementBalance Sheet
The company has $3.33 million in cash and $625,196 in debt, giving a net cash position of $2.70 million or $2.08 per share.
| Cash & Cash Equivalents | 3.33M |
| Total Debt | 625,196 |
| Net Cash | 2.70M |
| Net Cash Per Share | $2.08 |
| Equity (Book Value) | 10.20M |
| Book Value Per Share | 15.02 |
| Working Capital | 4.98M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.14M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.14M |
| FCF Per Share | -$3.96 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |